History

A list of downloadable documents created during development.

Background information

Leukaemia (chronic lymphocytic, first line) - rituximab: final appraisal determination

Leukaemia (chronic lymphocytic, first line) - rituximab: appraisal consultation

Leukaemia (chronic lymphocytic, first line) - rituximab: final scope (updated following CHMP positive opinion)

Leukaemia (chronic lymphocytic, first line) - rituximab: final scope

Leukaemia (chronic lymphocytic, first line) - rituximab: final matrix of consultees and commentators

Leukaemia (chronic lymphocytic, first line) - rituximab: comments on the draft scope

Leukaemia (chronic lymphocytic, first line) - rituximab: comments on the provisional matrix

Leukaemia (chronic lymphocytic, first line) - rituximab: draft scope

Leukaemia (chronic lymphocytic, first line) - rituximab: provisional matrix of consultees and commentators